Correlation Between Vincerx Pharma and Pulmatrix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Pulmatrix, you can compare the effects of market volatilities on Vincerx Pharma and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Pulmatrix.

Diversification Opportunities for Vincerx Pharma and Pulmatrix

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vincerx and Pulmatrix is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Pulmatrix go up and down completely randomly.

Pair Corralation between Vincerx Pharma and Pulmatrix

Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the Pulmatrix. In addition to that, Vincerx Pharma is 1.69 times more volatile than Pulmatrix. It trades about -0.01 of its total potential returns per unit of risk. Pulmatrix is currently generating about 0.05 per unit of volatility. If you would invest  379.00  in Pulmatrix on November 2, 2024 and sell it today you would earn a total of  388.00  from holding Pulmatrix or generate 102.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vincerx Pharma  vs.  Pulmatrix

 Performance 
       Timeline  
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Pulmatrix 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.

Vincerx Pharma and Pulmatrix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vincerx Pharma and Pulmatrix

The main advantage of trading using opposite Vincerx Pharma and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.
The idea behind Vincerx Pharma and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets